Delivery Order SPE2DX22D0010-SPE2D824FJH55
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $3,113.27 award is for the delivery of oxymorphone hydrochloride extended-release tablets, 15 milligrams. This delivery order falls under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order, valued at $7,547.36, is for the supply of Oxymorphone Hydrochloride Extended-Release Tablets, 20mg. The contract is a firm-fixed-price delivery order with an ultimate completion date of August 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts by the DLA and other...
- This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,107.93 firm fixed price contract is for the delivery of oxymorphone hydrochloride extended-release tablets with a completion date of May 6, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $6,672.25, is a firm fixed price delivery order for 4,564,082,819 units of Oxymorphone Hydrochloride Extended-Release Tablets 40mg. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 10 milligram oxymorphone hydrochloride extended release tablets. The $2,391.90 contract has a completion date of January 3, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp is an experienced prime contractor that has received numerous awards from DLA Troop Support...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 15mg oxymorphone hydrochloride extended-release tablets. The order, valued at $3,479.38, has a completion date of January 31, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Oxymorphone HCL ER Tablets 10mg, with a ceiling value of $7,897.52. This non-competitive delivery order, which is firm fixed price in nature, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The order is scheduled...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,276.50 firm fixed price delivery order is for the supply of Oxymorphone HCL ER Tablets 15mg, a pain management medication. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $3,850.93, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564965170 - Oxymorphone Hydrochloride Extended-Release Tablets, 15 mg. The contract has a period of performance through June 24, 2024 and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen, a major pharmaceutical distribution company, is not...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Oxymorphone HCL Extended Release tablets, 15mg. This firm fixed-price delivery order, valued at $1,864.16, represents a child contract under a larger indefinite delivery vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation and is...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FJH55Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,695.29 delivery order is for Oxymorphone Hydrochloride Extended-Release Tablets, 20 mg. The order has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 2/13/24 |